Humoral and cellular responses to repeated COVID-19 exposure in multiple sclerosis patients receiving B-cell depleting therapies: a single-center, one-year, prospective study
Roberto Alfonso-Dunn, Jerry Lin, Joyce Lei, Jiayuan Liu, Morgan Roche, Antonia De Oliveira, Amol Raisingani, Anjali Kumar, Vanessa Kirschner, Grant Feuer, Michaela Malin, Saud A Sadiq
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 August 2023.
All research outputs
#16,608,224
of 26,180,352 outputs
Outputs from Frontiers in immunology
#17,302
of 32,860 outputs
Outputs of similar age
#191,935
of 382,116 outputs
Outputs of similar age from Frontiers in immunology
#554
of 1,244 outputs
Altmetric has tracked 26,180,352 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 32,860 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 382,116 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,244 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.